What it's for (Indications)
- This combination topical antibiotic formulation, containing neomycin, bacitracin, and amino acids, is indicated for the prevention and treatment of superficial bacterial infections of the skin.
- It is primarily used for minor cuts, scrapes, burns, and other minor skin abrasions.
- The antimicrobial components target susceptible Gram-positive and Gram-negative bacteria that commonly cause skin infections.
- This product is not intended for the treatment of deep wounds, puncture wounds, animal bites, serious burns, or extensive skin infections, which require more comprehensive medical evaluation and management.
- Its utility is confined to the prevention of infection in minor skin trauma and the treatment of very localized, superficial bacterial dermatoses.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For topical administration only. A thin layer of the powder should be applied to the affected skin area one to three times daily, as directed by a healthcare professional or package instructions. Prior to application, the affected area should be thoroughly cleansed and dried. The treated area may be covered with a sterile dressing, if appropriate. The duration of therapy should be limited to the minimum necessary to achieve therapeutic effect, typically not exceeding seven days for minor conditions, to mitigate the risk of microbial resistance development and potential adverse effects. Excessive or prolonged application on large surface areas or compromised skin should be avoided due to the potential for increased systemic absorption. |
Safety & Warnings
Common Side Effects
- Adverse reactions to this topical formulation are generally localized and mild.
- Common side effects include localized skin irritation, erythema (redness), pruritus (itching), stinging, and the development of a rash or urticaria at the application site.
- Allergic contact dermatitis, particularly attributable to neomycin, is a well-documented and relatively common adverse event, manifesting as eczematous eruptions.
- Less frequently, but more seriously, systemic absorption, especially following application to extensive areas of compromised skin or prolonged use, can lead to ototoxicity (hearing impairment, vestibular dysfunction) and nephrotoxicity (renal impairment) due to the neomycin component.
- Additionally, prolonged or inappropriate use may predispose to the overgrowth of non-susceptible organisms, including fungi, leading to superinfection.
Serious Warnings
- Black Box Warning: While this product is intended for topical use, serious systemic adverse effects can occur if neomycin is absorbed in significant quantities. Neomycin, an aminoglycoside antibiotic, has the potential to cause irreversible ototoxicity (leading to partial or total hearing loss and vestibular dysfunction) and nephrotoxicity (resulting in kidney damage), particularly when applied to large areas of denuded or compromised skin, severe burns, or in patients with pre-existing renal impairment. Patients with a history of sensitivity to aminoglycosides are at increased risk. The use of this product on extensive skin surfaces, for prolonged periods, or in patients with impaired renal function necessitates extreme caution and vigilant monitoring for signs of systemic absorption and toxicity. Discontinue use immediately if any signs or symptoms suggestive of ototoxicity or nephrotoxicity, such as ringing in the ears, dizziness, hearing changes, or decreased urine output, are observed. Systemic absorption can be unpredictable and potentially life-threatening.
- This medication is strictly for external use only.
- Avoid contact with the eyes, mucous membranes, and internal body cavities.
- It should not be applied to large body surface areas, deep or puncture wounds, animal bites, or severe burns without explicit medical consultation and supervision, as such conditions necessitate specific therapeutic approaches and may increase the risk of systemic absorption.
- Discontinue use immediately if signs of hypersensitivity, irritation, or worsening of the skin condition occur.
- The neomycin component carries a risk of systemic absorption which, though rare with intact skin, can lead to serious ototoxicity and nephrotoxicity, particularly in patients with impaired renal function, extensive skin damage, or prolonged application.
- Caution is advised to prevent the development of microbial resistance and superinfections, especially with prolonged therapy, necessitating a reassessment of treatment if clinical improvement is not observed within a few days.
How it Works (Mechanism of Action)
The therapeutic action of this combination product is derived from its active antibiotic components. Neomycin, an aminoglycoside antibiotic, exerts its bactericidal effect by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria. This binding interferes with protein synthesis by causing misreading of mRNA, leading to the production of non-functional proteins and ultimately bacterial cell death. It is primarily effective against Gram-negative bacteria and some Gram-positive strains. Bacitracin, a polypeptide antibiotic, inhibits bacterial cell wall synthesis by preventing the dephosphorylation of undecaprenyl pyrophosphate, a lipid carrier molecule essential for the transport of peptidoglycan precursors across the bacterial membrane. This disruption primarily affects Gram-positive bacteria. The amino acids included in the formulation are generally considered supportive elements, potentially aiding in tissue repair and regeneration, though their direct antimicrobial contribution is not significant.
Commercial Brands (Alternatives)
No other brands found for this formula.